Sort by
Search results
ZYMUTEST Anti-β2-Glycoprotein IgG
Recurrent unexplained miscarriages. Unexplained lupus anticoagulant, without or with thrombosis. Anti-phospholipid syndrome. Any clinical situation where the assay of anti-β2GP1 auto antibodies is required.
ZYMUTEST PAI-1 Antigen
Assay of PAI-1: Ag in clinical samples. Measurement of PAI-1 as a cardiovascular risk factor. Assay of PAI-1 in diabetes or in metabolic disorders.
ZYMUTEST tPA Antigen
Assay of tPA:Ag in clinical samples, as a disease marker. Assay of tPA:Ag in thrombolysis with recombinant tPA drugs. Assay of tPA:Ag as a cardiovascular disease marker.
ZYMUTEST CRP-HS (High Sensivity)
Assay proposed for the measurement of C-reactive protein in research applications.
ZYMUTEST Factor V Antigen
Assay proposed for the measurement of factor V antigen in research applications.
ZYMUTEST TAFI (Total) Antigen
High TAFI Ag concentrations involve a hypofibrinolytic status, which can induce an elevated risk of thrombosis. Measurement of TAFI Ag on plasma in order to diagnose a risk of a hypofibrinolysis resulting from an excess of TAFI.
ZYMUTEST PF4 Antigen
Assay proposed for the measurement of platelet factor 4 in research application.
ZYMUTEST Anti-Annexin V IgM
Assay proposed for the measurement of IgM isotype auto antibodies targeted to annexin V in research applications.
ZYMUTEST Anti-Annexin-V IgG
Assay proposed for the measurement of IgG isotype auto antibodies targeted to annexin V in research applications.
ZYMUTEST Annexin V Antigen
Assay proposed for the measurement of annexin V in research applications.